The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
Open accessAbstract
Although central nervous system–resident microglia are believed to be ineffective at phagocytosing and clearing amyloid-β (Aβ), a major pathological hallmark of Alzheimer’s disease (AD), it has been suggested that peripheral myeloid cells constitute a heterogeneous cell population with greater Aβ-clearing capabilities. Here, we demonstrate that the conditional ablation of resident microglia in CD11b-HSVTK (TK) mice is followed by a rapid repopulation of the brain by peripherally derived myeloid cells. We used this system to directly assess the ability of peripheral macrophages to reduce Aβ plaque pathology and therefore depleted and replaced the pool of resident microglia with peripherally derived myeloid cells in Aβ-carrying APPPS1 mice crossed to TK mice (APPPS1;TK). Despite a nearly complete exchange of resident microglia with peripheral myeloid cells, there was no significant change in Aβ burden or APP processing in APPPS1;TK mice. Importantly, however, newly recruited peripheral myeloid cells failed to cluster around Aβ deposits. Even additional anti-Aβ antibody treatment aimed at engaging myeloid cells with amyloid plaques neither directed peripherally derived myeloid cells to amyloid plaques nor altered Aβ burden. These data demonstrate that mere recruitment of peripheral myeloid cells to the brain is insufficient in substantially clearing Aβ burden and suggest that specific additional triggers appear to be required to exploit the full potential of myeloid cell–based therapies for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“two recent studies showed that brain-engrafted bone marrow–derived cells either do not acquire microglial functions or do so only after a long time (202, 203).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [203]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with several studies showing that recruited myeloid cells are not as competent at restricting fAβ as resident microglia [48–50].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“in a transgenic CD11b-HSVTK mouse model, in which ganciclovir administration “paralyses” CD11b+ cells including microglia (i.e., where proliferation and activation is blocked), engrafted BM-derived monocytes failed to accumulate around Aβ plaques and did not reduce Aβ plaque burden [262]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“Interestingly, Trem2, a gene recently identified as a risk factor for AD (Guerreiro et al., 2013; Jonsson et al., 2013), also remained unchanged upon peripheral macrophage infiltration, suggesting that both resident microglia and peripheral myeloid cells can contribute to TREM2 protein expression…”
BackgroundNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“In contrast, there are examples in which modulation of the microglia response toward A did have a major impact on disease progression (vom Berg et al., 2012; Heneka et al., 2013; Chakrabarty et al., 2015; Guillot-Sestier et al., 2015).”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Self-citationLocal self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643 · cited 2×
“1 c), we achieved the exchange of resident microglia in the TK myeloid cells can enter the central nervous system (CNS) under certain conditions (Ajami et al., 2007; Mildner et al., 2011) and contribute to the immune response toward A deposits (Stalder et al., 2005).”
BackgroundThe microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · cited 2×
“In line with this notion, one has to keep in mind that previously published studies reporting effects of infiltrating macrophages on A pathology used genetic models to either prevent recruitment of peripheral myeloid cells, e.g., by deficiency in CCR2 (Mildner et al., 2011; Naert and Rivest, 2011),…”
BackgroundResultKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · cited 2×
“To exchange the resident microglia pool with peripheral myeloid cells in an A-carrying AD-like mouse model, we generated APPPS1;TK+/ mice by crossing APPPS1 (Radde et al., 2006) to TK mice (Heppner et al., 2005).”
MethodExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 2×
“To exchange the resident microglia pool with peripheral myeloid cells in an A-carrying AD-like mouse model, we generated APPPS1;TK+/ mice by crossing APPPS1 (Radde et al., 2006) to TK mice (Heppner et al., 2005).”
MethodSelf-citation
Cited by
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
“Also, during aging, inflammation in the brain gradually increases, a process termed ‘‘inflammaging’’ (Deleidi et al., 2015), and CNS leukocytes may also play a role in age-related inflammation and neurodegeneration (Baruch et al., 2013; Prokop et al., 2015; Ritzel et al., 2016).”
Self-citationFunctional morphology of the blood–brain barrier in health and disease
Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872
“However, more recent studies have challenged this view by showing that monocytes do not reduce the amyloid load, arguing against a role for circulating monocytes in Aβ clearance [97].”
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Metadata
- Authors
- Prokop, S., Miller, K. R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., & Heppner, F. L.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- VA Palo Alto Health Care System (US)
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305 2
- NeuroCure Cluster of Excellence (DE)
- Corresponding author
- Heppner, Frank L.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-10-12
- Volume
- 212
- Issue
- 11
- Pages
- 1811-1818
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4612091
- OpenAlex
- W1922340941
- Cited by
- 116
- References
- 28
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 7 · 2021: 6 · 2020: 13 · 2019: 10 · 2018: 19 · 2017: 18 · 2016: 11 · 2015: 3
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Research Portal (King's College London) (acceptedVersion, cc-by-nc-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TRR 43, NeuroCure EXC257, EXC257)
- Bundesministerium für Bildung und Forschung
- Berlin Institute of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglia, amyloid-beta clearance, Alzheimer's disease, APP/PS1 mice, myeloid cell recruitment, anti-amyloid antibodies, amyloid plaques, APP processing
- MeSH terms
- Alzheimer Disease, Animals, Cell Movement, Disease Models, Animal, Male, Vaccination, Ganciclovir, Amyloid beta-Peptides, Microglia, Myeloid Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice. https://app.cochat.ai/papers/10.1084/jem.20150479
- The paper
- Prokop, S., Miller, K. R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., & Heppner, F. L. (2015). Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20150479
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.